BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs7903146
,
LEP
,
Response to oxidative stress
,
Ischemia
,
Heart
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
STK17A
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
Spleen
Whole blood
Lymph nodes
Tongue superior part with papillae
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
Degradation of DRAK1 by CUL3/SPOP E3 Ubiquitin ligase promotes tumor growth of paclitaxel-resistant …
Inhibition of miR-182-5p attenuates ROS and protects against myocardial ischemia-reperfusion injury …
Mechanistic Insights into the Mechanism of Inhibitor Selectivity toward the Dark Kinase STK17B again…
Drak/STK17A Drives Neoplastic Glial Proliferation through Modulation of MRLC Signaling.
RNase L Induces Expression of A Novel Serine/Threonine Protein Kinase, DRAK1, to Promote Apoptosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for STK17A
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ